Companion diagnostics are a form of in-vitro diagnostics which provide data about the therapeutic reactions of patients for a particular treatment. Companion diagnostics market is still developing, and it is expected to reach a market value of $3.5 billion by 2020 from a market value of $1.1 billion in the year 2013, registering a CAGR of 20% during 2014-2020.
Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020. The global companion diagnostic market is segmented based on indication, technology and geography (North America, Europe, Asia Pacific and LAMEA). Read the Complete Report @ http://www.researchbeam.com/companion-diagnostic-technologies-market
A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy.
A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy.
Rise in prominence of personalized medicine, surge in cases of adverse drug reactions, and advancements in technologies for diagnostic techniques drive the growth in the global companion diagnostics market.
This report, from Stratview Research, studies the global clinical diagnostics market - companion diagnostics over the trend period of 2014 to 2017 and forecast period of 2018 to 2025.
The Global Companion Diagnostics Market size is expected to reach $6.5 billion by 2025, rising at a market growth of 19.9% CAGR during the forecast period. A companion diagnostics test is done to understand which patient can gain benefits from a specific drug or decide upon the kind of dosage that should be prescribed. All of this, on the basis of a patients clinical diagnosis, which offers required evidence for the successful and harmless utilization of an equivalent biological or drug product to treat the medical issue. These can also be referred to as medical instruments that help doctors in electing which dosage or treatment is sufficient for patients and suits to their necessity. Full Report: https://www.kbvresearch.com/companion-diagnostics-market/
Companion Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource.
Looking forward, the companion diagnostics market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/companion-diagnostics-market
This report describes the current technologies that are propelling the personalized medicine and companion diagnostic market. See Full Report: http://goo.gl/daXMJ8
The new Companion Animal Diagnostic Market report offers a comprehensive study of the present scenario of the market coupled with major market dynamic. Also, it highlights the in-depth market analysis with the latest trends, drivers and its segments with respect to regional and country. Further, this report profiles top key players of the companion animal diagnostic and analyze their market share, strategic development and other development across the globe.
The Companion Diagnostics Market deals with the development of tests to comprehend which patient can be profited from a specific medication or what dose ought to be recommended in light of a patient's clinical conclusion, which gives the confirmation of required effective and innocuous utilization of a proportional medication or natural item to treat the restorative condition. Such medicinal instruments, produced by companion diagnostic companies, guide specialists to choose which treatment and measurements ought to be given to patients and are customized to their needs.
This report covers market size and forecasts of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx), including the following market information: Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
This report describes the current technologies that are propelling the personalized medicine and companion diagnostic market. It examines the current genetic diagnostic tests and companion diagnostic assays that are in use by the medical and pharmaceutical industry today. Current developments in personalized medicine and the pharmacogenomics revolution are discussed.
The Global And China Companion Diagnostic Tests Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Companion Diagnostic Tests industry.
The report provides value and growth of the global personal therapeutics market from 2017-2021. Also historic figures back to 2014 are given to illustrate growth. As the personal targeted therapeutics market is part of the overall personalized medicine market, the companion diagnostics market is also included in the report
The report provides a detailed understanding and analysis of how and why companies enter companion diagnostic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors companion diagnostics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Companion diagnostics can allow for a specific patient population to be identified which will ensure those patients who are most likely to respond are recruited for clinical trials and receive the therapy once the product is launched. Companion diagnostics can help to rationalize treatment decisions, with specifics such as accurate dosing, risks of adverse events and diagnostics being made possible through these tests. Through the use of companion diagnostics, the right treatment can be delivered to the right patient at the right time, delivering greater value and optimizing healthcare resource utilization
The molecular diagnostics market is expected to grow at a CAGR of 9.3% to reach USD 9,333.8 Million by 2020. High prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system are driving the growth of the market.
JSB Market Research published latest report titled "Global and USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)" Browse complete report @ http://goo.gl/CYCwde
[320 Pages Report] Tissue Diagnostics Market report categories the Global market by Technology (Digital pathology & Workflow, Immunohistochemistry, in Situ Hybridization, Special Staining), Disease (Breast Cancer, Lymphoma, Gastric Cancer, Non Small Cell Lung Cancer , Prostate Cancer and Others), Product, End-Users & by Region (The Americas, Europe, BRIC, Japan & RoW)
Alfa Wassermann Diagnostic Technologies, LLC (AWDT) is the provider of medical diagnostic instrumentation and reagents to the medical community. It offers diagnostics equipment to the physician office and veterinary lab markets. The product portfolio of the company comprises ACE Axcel Clinical Chemistry System, ACE Alera Chemistry System, Alfa Laboratory Information System (LIS), Vet Alera Chemistry Analyzer and Vet LIS. It operates as the subsidiary of Alfa Wassermann, Inc. AWDT is headquartered in New Jersey, the US.
Biomarker technology is evidencing increased application from key segments such as disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. Biomarkers are novel diagnostic solutions and advancement in it its development and understanding of human genome promotes its application in diagnosis of disease on molecular basis. Pharmaceutical companies which are interested in introducing novel diagnostic solution are increasing partnership and collaboration with private laboratories, educational institute and these companies are also increasing their investments in research and development. Get full report & TOC @: http://www.researchbeam.com/biomarkers-market
Aarkstore.com is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service
The global molecular diagnostics market is expected to see innovation driven growth. With recent outbreak of infectious. For more mail: vikas@konceptanalytics.com
Get more details @ http://bit.ly/2ekRPfD Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics.
Research Beam added report on "Chinese Veterinary Diagnostic Industry Development, Size, Share, Trends, Segmentation, Growth, Technology, Opportunity, Analysis and Forecast 2015" Enquiry about report: http://www.researchbeam.com/outlook-of-global-and-chinese-veterinary-diagnostic-industry-2015-2020-market/enquire-about-report
Bharatbook.com announces a new report on "Companion Biomarkers in Drug Development", Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic.
The report, Companion Diagnostics - Streamlining drug development and advancing personalized medicine was written to support both the biopharmaceutical and diagnostic industries better understand the current challenges involved in developing products with a companion diagnostic, as well as the opportunities that will exist in the future. See Full Report : http://bit.ly/19vXOJP
The Global Cancer Diagnostics Partnering Market Report contains over 1,000 links to online copies of actual cancer diagnostics deals and where available, contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
The Global Cancer Diagnostics Partnering Market Report contains over 1,000 links to online copies of actual cancer diagnostics deals and where available, contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
“Text analytics” is an emerging technology that is popular amongst various industries such as FMCG, BFSI, Telecom, Healthcare, etc. For More Details : http://goo.gl/u6nQoS
Bharatbook.com announces a new report on "GLOBAL & USA CANCER BIOMARKER MARKET", One of the most import aspects of biomarkers is their use to diagnose and assess the progress of disease states in patients.
The market is driven by factors such as the increased demand for convenience foods and fast food due to growing urbanization. Furthermore, innovative product offerings have also increased the demand for cheese powder. See Full Report: http://goo.gl/e2j3sn
Access Full Research: https://www.renub.com/global-molecular-diagnostics-market-opportunities-and-future-forecast-414-p.php As per Renub Research analysis Global molecular diagnostics market is projected to become US$ 20.5 Billion opportunities by the year 2024, owing a significant growth during the forecast period. Some of the key factors that can be attributed to the growth of the molecular diagnostics market include rising prevalence of diseases, including cancers, growing awareness and acceptance of companion & personalized diagnostics and advancement in the molecular diagnostics techniques. Furthermore; rising incidence of neurological, cardiovascular and genetic disorders also helps molecular diagnostics market thrive in the coming years.
Global veterinary diagnostics market http://goo.gl/Bywj8u . It is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded a major share of the veterinary diagnostics market. This is mainly due to the increasing adoption of companion animals, growing pet insurance industry, increasing demand for animal-derived food products, and rising veterinary healthcare expenditure in the region.
“Personalized Medicine and Companion Diagnostic Market - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment” is a cutting-edge comprehensive report on the personalized medicine industry and its impact on the health system. This report tackles the growing market interest in pharmacogenomics, companion diagnostics and the associated market environment. See Full Report : http://bit.ly/1xTcMmO
Animal Health Market Size, Share and Industry Analysis By Product (Drugs, Vaccines, Feed, and Diagnostics), By Animal (Livestock Animals and Companion Animals), By End User (Veterinary Hospitals & Clinics, Animal Care & Rehabilitation Centers, Diagnostic Centers, and Others) and Geography Forecast, 2019-2026 For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/animal-health-market-102371
The global animal health market size is anticipated to reach USD 67.56 billion by 2026 owing to the increasing number of animal health issues worldwide. Animals have always been of immense help to man either as companions or as livestock. With time, man starting adopting animals and keeping them as pets. Animals, alike humans, are susceptible to infections and diseases and require medical aid. As per a recently published report by Fortune Business insights™ titled, “Animal Health Market Size, Share and Global Trend By Product (Drugs, Vaccines, Feed, and Diagnostics), By Animal (Livestock Animals and Companion Animals), By End User (Veterinary Hospitals & Clinics, Animal Care & Rehabilitation Centers, Diagnostic Centers, and Others) and Geography Forecast till 2026” the market size was USD 41.50 billion in 2018 and is anticipated to rise at a CAGR of 6.3%. For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/animal-health-market-10237
Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=313491. Tissue diagnostics involve the diagnosis of diseases or analysis of the biological context of the disease by extracting and analyzing the specific tissue context. It has a wide range of applications in clinical diagnostics, clinical research, and cell biology. It is considered as the most accurate and inexpensive technique for diagnosis of diseases such as cancer and inflammatory conditions. In cancer diagnosis, it is widely used for detecting breast cancer, NSCLC, lymphoma, stomach cancer, and prostate cancer. Various technologies such as IHC, ISH, digital pathology, and special staining are used to study the cell. Tissue diagnostics can be carried out by different methods such as FNAC, core biopsy, and open biopsy.
Complete report is available @ http://www.reportsnreports.com/reports/287211-medipoint-companion-diagnostic-tests-in-oncology-south-america-analysis-and-market-forecasts.html . A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy. This report provides an analysis of the companion diagnostic market for four major cancers in the US, the 5EU (France, Germany, Italy, Spain, and UK), Brazil, and the some of the Asia-Pacific (APAC) regions (Japan, China, and India), and identifies the unmet needs in this companion diagnostics market.
According to #TechSci Research report, Global Precision Medicine Market, was valued USD66.85 billion in 2020 and is expected to reach USD125.67 billion, growing at CAGR of 10.65% during the forecast period. Gain More Insight: https://bit.ly/3Df5kr2 Get Sample Report: https://bit.ly/3kneqJG Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and Pipeline Analysis)” is a comprehensive report on the cancer biomarker industry and its impact on the health system. This report tackles the growing market interest in oncogenic biomarkers, personalized medicine, companion diagnostics and the associated market environment. Complete report available @ http://www.lifescienceindustryresearch.com/global-usa-cancer-biomarker-market-to-2018-identification-technologies-market-analysis-competitor-profiles-companion-diagnostic-co-development-business-strategies-industry-trends-and-pipelin.html.
Complete report is available @ http://www.reportsnreports.com/reports/287209-medipoint-companion-diagnostic-tests-in-oncology-us-analysis-and-market-forecasts.html . This report analyses companion diagnostic tests used in breast, colorectal, melanoma and non-small cell lung cancer. This report also discusses physician attitudes towards current companion diagnostic tests, and the future of companion diagnostic tests. This report focuses on the major test kits that are supplied to pathology laboratories. The major feature of the companion diagnostic testing market is the current domination of tests for mutations important in the prognosis and diagnosis of non-small cell lung cancer (NSCLC), with the two market leaders being Roche and Qiagen. According to Researcher’s forecast, in 2014, NSCLC companion diagnostic tests account for 67% of the US market by value. While more human epidermal growth factor receptor 2 (HER2) tests are carried out
Complete report is available @ http://www.reportsnreports.com/reports/287212-medipoint-companion-diagnostic-tests-in-oncology-apac-analysis-and-market-forecasts.html . Researcher estimates the APAC companion diagnostic test market, for breast cancer companion diagnostic tests, principally HER2 tests, to have been worth $12.9m in 2012. In China, there has been excellent progress in uptake of HER2 testing among the urban population, thanks to efforts to train pathologists, with IHC uptake rates expected to be comparable to western countries by 2014.
The global skincare devices market is expected to grow in the future, due to the increasing rate of skin-related disorders, worldwide. Technological advancement in designing these devices, which are highly efficient and growing preference for them due to non-invasive procedures are the key drivers for the growth of this market. Additionally, rise in the demand for aesthetic processes such as skin rejuvenation, skin tightening, body contouring and liposuction will also drive the growth of the skincare devices market in the future. Detailed report at: http://www.reportsandintelligence.com/skincare-devices-market
Complete report is available @ http://www.reportsnreports.com/reports/287210-medipoint-companion-diagnostic-tests-in-oncology-eu-analysis-and-market-forecasts.html . A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy. This report provides an analysis of the companion diagnostic market for four major cancers in the US, the 5EU (France, Germany, Italy, Spain, and UK), Brazil, and the some of the Asia-Pacific (APAC) regions (Japan, China, and India), and identifies the unmet needs in this companion diagnostics market.